Remove Hospitals Remove Insurance Coverage and Processing Remove Pharmaceutical Manufacturing
article thumbnail

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

Otsuka Pharmaceutical president and representative director Makoto Inoue noted: “HBM7020 is expected to demonstrate efficacy in a broad range of autoimmune diseases in which B cells play a major role in disease pathogenesis, and we hope to contribute further to the field of specialised autoimmune diseases and thereby benefit patients.”

article thumbnail

Pharmacy Policy Updates for June 2025

Pharmacy Times

The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Building Intelligent Pharma Supply Chain Management with Real-World Data

Pharmaceutical Commerce

Intelligent medication management systems using RWD help hospitals forecast demand, respond to crises, and minimize medication expiration and loss, ultimately improving patient care and operational efficiency. million drugs are given or prescribed annually in hospital emergency departments alone.

article thumbnail

Formularies, Formulary Strategies, and Vigilante Formulary Review

Ramblings of a pharmacist

Hospitals and health systems maintain formularies of products that they will stock in the hospital pharmacy and administer to inpatients. Health insurance providers do the same, and usually outsource this function to Pharmacy Benefit Managers. Paying $1980/month for 30,000 mg of baking soda is, frankly, insane.

article thumbnail

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

FDA cell and gene therapy director exit increases ‘volatility’ for sector

Pharmaceutical Technology

Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.

article thumbnail

Bridging the gap: A comprehensive approach to social determinants of health

Pharmaceutical Technology

Better insights into how SDoH affects health can highlight the systemic influences that leave certain groups with worse health outcomes than others, despite similar health insurance coverage or access. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.